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ABSTRACT 
A skin disease, like acne, is very common and normally happens to everyone at least once in their lifetime. The structure of the 
stratum corneum is often compared with a brick wall, with corneocytes surrounded by the mortar of the intercellular lipid lamellae. 
One of the best options for successful drug delivery to the affected area of skin is the use of ethosomes which can be transported 
through the skin through channel-like structures. Tretinoin is a widely used retinoid for the topical treatment of acne, photo-aged 
skin, psoriasis and skin cancer which makes it a good candidate for topical formulation. Yet side effects, like redness, swelling, 
peeling, blistering and, erythema, in addition to its high lipophilicity make this challenging. Drug loaded ethosomes had been 
prepared using phospholipid and ethanol, were optimized and characterized for entrapment efficiency, vesicular size, shape, In-vitro 
skin permeation, skin retention, drug‐membrane component interaction and stability. The ethosomal formulation having 0.5 %w/v of 
phospholipid and 20 %v/v of ethanol (F2) showing the greatest entrapment efficiency (80.25±0.23) with small particle size 
(205.40±2.31nm) was selected for further skin permeation studies. The skin permeation and skin retention studies were performed 
on ethosomal formulation, liposomal formulation (0.5 %w/v of phospholipid without alcohol), hydroethanolic drug solution and 
phosphate buffer saline (pH7.4) drug solution. Among them, ethosomal formulation showed higher cumulative percentage of drug 
permeation (93.36±0.45%) and 8 hours than the other formulations. Scanning electron microscopy confirmed the three dimensional 
nature of ethosomes. Dynamic light scattering technique proved that the ethosomes has smaller vesicular size than the liposomes 
prepared without alcohol. FT‐IR studies revealed no interaction between the drug and membrane components. The ethosomal 
vesicles were incorporated in carbopol gel base and its anti‐acne was compared with the marketed gel. Our results suggest that the 
ethosomes are an efficient carrier for dermal and transdermal delivery of tretinoin. 
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INTRODUCTION  
The optimization of drug delivery through human skin is 
important in modern therapy. Clearly, the topical route 
of drug delivery for treating skin diseases offers an 
attractive alternative to the conventional drug delivery 
methods of oral administration/injection and it is 
becoming a most innovative research area in drug 
delivery. A skin disease like acne, is very common and 
normally happens to everyone once in their lifetime. 
Acne vulgaris is a chronic inflammatory dermatosis 
which is notable for open and/or closed comedones 
(blackheads and whiteheads) and inflammatory lesions 
including papules, pustules or nodules. It is a disorder of 
sebaceous follicles which are special pilosebaceous units 
located on the face, chest and back 
1
. Propionibacterium 
acnes and Staphylococcus epidermidis have been 
recognized as pus-forming bacteria triggering 
inflammation in acne 
2
. 
The organism produces extracellular lipases that 
hydrolyze sebum triglycerides to glycerol and free fatty 
acids that have proinflammatory properties 
3
. The topical 
treatment of acne includes topical retinoids 
4,5
, benzoyl 
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peroxide (BPO) 
4,6
, azelaic acid 
7
, erythromycin 
8
, 
clindamycin 
8
 and combination therapies 
9,10
. The 
adverse effects of topical antiacne agents include 
burning, erythema, scaling, flare-up, photosensitivity 
and bacterial resistance 
4
. Tretinoin are used individually 
and in a cyclic manner for acne treatment. Various 
conventional topical medicines are available in the 
market for treatment but have a less therapeutic effect 
due to the efficient barrier properties of skin membranes. 
The structure of the stratum corneum is often compared 
with a brick wall made of corneocytes and surrounded 
by the mortar of the intercellular lipid lamellae 
11
. The 
best alternative for successful drug delivery to an 
affected area of skin is elastic vesicles (ethosomes) 
which can be transported through the skin via channel-
like structures. Moreover, they are too small in the 
nanometer size range to be detected by the immune 
system; furthermore, they can deliver the drug to the 
target site using lower drug doses in order to reduce side 
effects often experienced by topical routes by passing 
the complexity of the skin structure 
12
. The main 
advantages of using nanocarriers arise from their 
peculiar features, such as their tiny size, high surface 
energy, high surface area, composition and architecture 
12
. The use of lipid vesicles in delivery systems for skin 
treatment has attracted increasing attention in recent 
years 
13, 14
. However, it is generally agreed that classic 
liposomes are of little or no value as carriers for 
transdermal drug delivery because they do not deeply 
penetrate the skin, but rather remain confined to the 
upper layer of the stratum corneum 
13
. Only specially 
designed vesicles were shown to be able to allow 
transdermal delivery 
15
. Ethanol is known as an efficient 
permeation enhancer 
16
. However, due to the 
interdigitation effect of ethanol on lipid bilayers, it was 
commonly believed that vesicles cannot coexist with 
high concentrations of ethanol. Currently, ethanol can 
only be found in relatively low concentrations in 
liposomes formulations, if at all. We have discovered 
and have been investigating lipid vesicular systems 
embodying ethanol in relatively high concentrations, 
which we named ethosomes and that are very efficient at 
enhancing the skin permeation of a number of drugs 
17–
20
. These findings are supported by other recent reports 
21,22
. The present paper focuses on the characterization of 
ethosomal systems and presents the enhancing delivery 
properties of these systems. 
MATERIALS AND METHODS 
Tretinoin was obtained as a gift sample from Bioplus 
Life science, Bangalore. Phosphatidylcholines from 
Himedia mumbai. Ethanol and Propylene glycol from 
SD Fine chemicals Mumbai. All other chemicals and 
reagent were of analytical grade. 
Preparation of ethosomes 
Ethosomal formulations were prepared by as reported by 
23
. In brief the lecithin (1-4%w/v) was taken in small 
round bottom flask and solubilized with ethanol (10-
50%) containing drug under mixing with a magnetic 
stirrer. The round bottom flask was covered to avoid 
ethanol evaporation. Distilled water was added slowly 
with continuous stirring to obtain the ethosomal 
colloidal suspensions. The final suspension of ethosomes 
was kept at room temperature for 30 min. under 
continuous stirring. Formulation was stored in the 
refrigerator. The composition of various ethosomal 
formulations and liposomal formulation were 
represented in table 1. 
 
Table 1: Different Composition of ethosomes formulation 
F. Code Drug (mg) Phospholipid 
(% w/v) 
Ethanol 
(% w/v) 
PEG 
(%w/v) 
Water 
(%w/v) 
F1 100 0.5 10 20 100 
F2 100 0.5 20 20 100 
F3 100 0.5 30 20 100 
F4 100 1.0 10 20 100 
F5 100 1.0 20 20 100 
F6 100 1.0 30 20 100 
 
Evaluation of ethosomes 
Microscopic observation of prepared ethosomes
  
An optical microscope (cippon, Japan) with a camera 
attachment (Minolta) was used to observe the shape of 
the prepared ethosomes formulation.  
Vesicle size and zeta potential  
Vesicle size and zeta potential of the Ethosomes were 
measured by photon correlation spectroscopy using a 
horiba scientific, nanoparticle analyzer instrument the 
results shown in table 2.  
Entrapment efficiency 
Entrapment efficiency was determined by measuring the 
concentration of unentrapped free drug in aqueous 
medium. About 1 ml of the drug loaded ethosomes 
dispersion was placed in the eppendorf tubes and 
centrifuged at 10,000 rpm for 30 min. The ethosomes 
along with encapsulated drug were separated at the 
bottom of the tubes. Plain ethosomes without Tretinoin 
was used as blank sample and centrifuged in the same 
manner. In order to measure the free drug concentration, 
the UV absorbance of the supernatant was determined at 
322 nm. The results shown in table 2a. 
Visualization by scanning electron microscopy 
(SEM) 
The size and shape of the vesicles were observed in the 
scanning electron microscopy. One drop of ethosomal 
suspension (F2) was mounted on a clear glass stub. It 
was then air dried and gold coated using sodium auro 
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thiomalate to visualize under scanning electron 
microscope at 10,000 magnifications. 
FTIR studies  
The interaction between ethosomal membrane 
component and drug was observed from IR‐Spectral 
studies by observing any shift in peaks of drug in the 
spectrum of physical mixture of drug and 
phosphatidylcholine. 
Stability studies  
Stability studies were carried out by storing the 
ethosomal formulations at two different temperatures 
4
o
C and 25±2
o
C. The drug content was estimated for 
every 15 days to identify any change in the entrapment 
efficiency of ethosomal formulation. 
Preparation of ethosomal gel 
The incorporation of the drug loaded ethosomes 
(equivalent to 2%) into gels was achieved by slow 
mechanical mixing at 25 rpm (REMI type BS stirrer) for 
10 minutes. The optimized formulation was 
incorporated into three different carbapol gel 
concentration 0.5, 1 and 2% w/w. 
Evaluation of gel  
Physical Characteristic  
The Physical Characteristic was checked for gel 
formulations (homogeneity and texture) and 
observations were shown in Table 3.  
Determination of pH  
The pH of the gel was determined by digital pH meter. 
One gram of gel was dissolved in 25 ml of distilled 
water and the electrode was then dipped in to gel 
formulation for 30 min until constant reading obtained.  
And constant reading was noted. The measurements of 
pH of each formulation were replicated two times (table 
4). 
Washability  
Formulations were applied on the skin and then ease and 
extent of washing with water were checked manually 
and observations were shown in Table 3. 
Extrudability study  
The gel formulations were filled into collapsible metal 
tubes or aluminium collapsible tubes. The tubes were 
pressed to extrude the material and the extrudability of 
the formulation was checked in table 3.  
Assay  
Weight equivalent to 10 mg of ethosomal gel dissolved 
in 5 ml methanol in 10 ml volumetric flask, sonicate it 
for 10 min and volume make up to 10 ml and dilute 
suitably to 10µg/ml and take the absorbance at 322nm 
and calculate using calibration curve of linearity. 
Spreadability  
An important criterion for gels is that it must possess 
good spreadability. Spreadability is a term expressed to 
denote the extent of area to which the gel readily spreads 
on application area. The therapeutic efficacy of a 
formulation also depends on its spreading value.  A 
special apparatus has been designed to study the 
spreadability of the formulations. Spreadability is 
expressed in terms of time in seconds taken by two 
slides to slip of from formulation, placed between, under 
the application of a certain load. Lesser the time taken 
for the separation of two slides, better the spreadability. 
Two glass slides of standard dimensions (6×2) were 
selected. The gel formulation whose spreadability had to 
be determined was placed over one of the slides. The 
second slide was placed over the slide in such a way that 
the formulation was sandwiched between them across a 
length of 6 cms along the slide. 100 grams of weight 
was placed up on the upper slide so that the gel 
formulation between the two slides was traced 
uniformly to form a thin layer. The weight was removed 
and the excess of the gel formulation adhering to the 
slides was scrapped off. The lower slide was fixed on 
the board of the apparatus and one end of the upper slide 
was tied to a string to which 20 gram load could be 
applied   50 with the help of a simple pulley. The time 
taken for the upper slide to travel the distance of 6 cms 
and separate away from lower slide under the direction 
of the weight was noted. The experiment was repeated 
and the average of 6 such determinations was calculated 
for each gel formulation (Table3). 
Viscosity  
The measurement of viscosity of the prepared gel was 
done using Brookfield digital Viscometer. The viscosity 
was measured using spindle no. 6 at 10 rpm and 25
0
C. 
The sufficient quantity of gel was filled in appropriate 
wide mouth container. The gel  was  filled  in  the  wide  
mouth  container in such way that it should  sufficiently  
allow  to  dip  the  spindle of the Viscometer. Samples 
of the gels were allowed to settle over 30 min at the 
constant temperature (25 ±/1
0
C) before the 
measurements (Table 4).  
In-vitro drug release studies using the semipermeable 
membrane Preparation of semipermeable membrane 
for the diffusion studies:  
The semipermeable membrane approximately 25 cm x 
2cm was taken and washed in the running water. It was 
then soaked in distilled water for 24 hours, before used 
for diffusion studies to remove glycerin present on it and 
was mounted on the diffusion cell for further 
studies.The prepared Ethosomes delivery system was 
evaluated for in vitro drug release. The drug release 
studies were carried out using modified franz diffusion 
cell. The dissolution study was carried out in 24 ml 
dissolution medium which was stirred at 50 rpm 
maintained at 37±0.2C. Samples were withdrawn at 
different time interval and compensated with same 
amount of fresh dissolution medium. Volume of sample 
withdrawn was made up to 10ml by PBS (pH 7.4). The 
samples withdrawn were assayed 
spectrophotometrically at 322.0 nm for Tretinoin and 
using UV visible spectrophotometer. The release of 
Tretinoin was calculated with the help of Standard curve 
of Tretinoin. The observations of drug release for the 
drug in uncoated formulation and coated formulation is 
tabulated in Table 5 and fig 1. 
 
Mishra et al                                                                                               Journal of Drug Delivery & Therapeutics. 2018; 8(5-s):315-321           
ISSN: 2250-1177                                                                             [318]                                                                             CODEN (USA): JDDTAO 
Release kinetics 
In-vitro diffusion has been recognized as an important 
element in drug development. Under certain conditions 
it can be used as a surrogate for the assessment of 
bioequivalence. Several theories/kinetic models describe 
drug dissolution from immediate and modified release 
dosage forms. There are several models to represent the 
drug dissolution profiles where ft is the function of t 
(time) related to the amount of drug dissolved from the 
pharmaceutical dosage system. To compare dissolution 
profiles between two drug products model dependent 
(curve fitting), statistic analysis and model independent 
methods can be used. The following plots were made: 
cumulative % drug release vs. time (zero order kinetic 
models); log cumulative of % drug remaining vs. time 
(first order kinetic model); cumulative % drug release 
vs. square root of time (Higuchi model) results are 
shown in table 5 and fig 2-4. 
Stability Studies 
Stability studies were carried out with optimized 
formulation which was stored for a period of 45 days at 
4±1°C, RT and 40±1°C. The particle size of formulation 
was determined by optical microscopy using a calibrated 
ocular micrometer. The vesicle size of the ethosomes 
was found to increase at RT, which may be attributed to 
the aggregation of ethosomes at higher temperature. At 
452°C the aggregate i.e. these ethosomes were unstable 
at higher temperature like 452°C. Percent efficiency of 
ethosomes also decrease at higher temperature like 
452°C. 
RESULTS AND DISCUSSION 
Preformulation studies are essential protocols for 
improvement of safety, efficacy and stability of dosage 
form as well. Thus it plays an important role in order to 
ensure optimum condition for clinically advantageous 
delivery system. Organoleptic property: Drug 
substances which irritates to skin should be handle with 
precautions. Flavors, dyes, excipients used will affect 
stability and bioavailability of dosage form. Color of the 
tretinoin was found to be white to almost white powder 
and no Odor. Solubility: One important goal of the 
pre‐formulation studies is to device a method to check 
the solubility of drug. Solubility of the drug was 
determined by taking weighed quantity of drug (about 1-
2 mg) in the test tube separately and added the 10 ml of 
the solvent. Tretinoin was soluble in methanol, 
Chloroform and 7.2 phosphate buffer, Slightly soluble 
in 0.1N NaOH, and 0.1N HCL and water. FTIR 
spectroscopy: Identification and authentication of drug 
sample was done by infrared spectroscopy. The IR 
spectra showed the presence of principal group like at 
2876.86 C-H aromatic stretching; 1636.38 C=O stretch 
and 682.25.19 of CH bending (aromatic) which 
confirm the drug is tretinoin. Loss on drying: Loss on 
drying is directly measured by IR moisture balance. 
Firstly instrument is calibrated by knob then 5.00 gm of 
drug (powder) was taken and temp was set at 100°C to 
105°C for 15 minutes and constant reading was taken 
again set the knob and check % moisture. The 
percentage of loss on drying of tretinoin was found to be 
0.25% w/w respectively. Melting point: Melting point 
was determined by Melting point apparatus using open 
capillary method and found to be in the range of 180-
182°C for tretinoin. Moisture content: Moisture content 
determination was done by Karl Fischer colorimetric 
method. tretinoin Moisture content was found to be 
0.13%. Determination of λ max of tretinoin: 
Identification of tretinoin was performed by UV/VIS 
Spectroscopy. The 10 µg/ml solutions of tretinoin was 
scanned in the range of 200-400nm to determine the 
wavelength of maximum absorption for drug. The λmax 
of tretinoin was found to be 322.00nm. From the 
respective stock solution (1mg/ml) different 
concentration of 5,10,15,20 and 25 µg/ml tretinoin was 
prepared and scanned in UV region. Their absorbances 
were noted at ʎmax, 322 nm and calibration curve was 
plotted as absorbance Vs concentration and their 
linearity range was determined. Compatibility studies of 
drug and excipients: In the compatibility testing study 
blends of drug and excipients are prepared by triturating 
the drug with excipients. The lambda max does not 
deviate from 322nm shows that there is no interaction 
between drug and excipients. Ethosomal formulations 
were prepared by hand shaking method. Total six 
formulations were prepared using varying amount of 
phospholipids and ethanol. The prepared formulation 
was evaluated for Microscopic observation, Vesicle size, 
zeta potential and Entrapment efficiency. The maximum 
entrapment efficiency was observed in formulation F2, 
was further subjected for zeta potential and particle size. 
The particle size and zeta potential was found to be 
205.4 and -0.9mv respectively. The optimized 
formulation of ethosomes was further incorporated into 
carbopol gel base (0.5, 1.0 and 1.5%) and evaluated for 
Physical Characteristic pH, Washability, Extrudability 
study, Spreadability, Viscosity and In-vitro Drug 
Release Studies Using the semipermeable membrane. In 
all formulation formulation F2 select as a optimized 
formulation because of its good Spreadability 
(15.56±0.35), Viscosity (3215±58) and pH (7.10±0.15). 
The maximum % assay was also found in formulation 
F2 (96.56±0.15). The in vitro drug release data of the 
formulation was subjected to goodness of fit test by 
linear regression analysis according to zero order, first 
order kinetic equation and Korsmeyer’s models in order 
to determine the mechanism of drug release. When the 
regression coefficient values of were compared, it was 
observed that ‘r’ values of formulation was maximum 
i.e 0.978 hence indicating drug release from 
formulations was found to follow Pappas model of drug 
release kinetics. 
Table 2: Result for Vesicle size and Entrapment 
efficiency of drug loaded Ethosomes 
Formulation 
Code 
Vesicle size Entrapment 
Efficiency 
F1 215.56±3.25 65.58±0.51 
F2 232.56±4.56 72.65±0.84 
F3 205.40±2.31 80.25±0.23 
F4 265.50±4.58 75.65±0.21 
F5 260.12±5.65 70.14±0.65 
F6 272.56±4.10 76.65±0.45 
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Table 2a: Vesicle size and entrapment efficiency of optimized ethosomes 
Formulation Code Vesicle size (nm) Entrapment Efficiency Zeta potential 
F2 205.4 80.25±0.23 -31mv 
 
Table 3: Results of Homogeneity, Extrudability, Spreadability of gel formulation 
Code 
Homogeneity and 
Texture 
Spreadability 
(gm.cm/sec.) 
Extrudability Washability 
F1 +++ 18.56±0.45 +++ Good 
F2 +++ 15.56±0.35 +++ Good 
F3 ++ 13.56±0.25 +++ Good 
+++ Good          ++ Average 
Table 4: Results of pH, Viscosity and % Assay 
Code pH Viscosity (cps) % Assay 
F1 6.90±0.21 3325±45 90.25±0.21 
F2 7.10±0.15 3215±58 95.56±0.12 
F3 7.15±0.045 3014±60 91.25±0.25 
 
Table 5: Cumulative % drug release of Tretinoin from optimized ethosomes formulation 
Time (hrs) 
% Cumulative Drug Release 
(Marketed formulation) 
% Cumulative Drug Release 
Ethosomal gel 
0.5 45.65±0.45 33.25±0.20 
1 86.56±0.89 45.59±0.31 
2 99.78±0.78 65.56±0.43 
4 - 72.25±0.66 
6 - 85.65±0.69 
8 - 93.36±0.45 
10 - 99.15±0.36 
 
 
Figure 1: Comparative in vitro drug release, Cumulative Percent Drug Released Vs Time 
Table 6: In Vitro Drug Release Data for optimized gel formulation F2 
S. No. 
Time 
(H) 
Square 
Root of 
Time 
Log Time 
Cumulative* 
Percentage 
Drug Release ± 
SD 
Log 
Cumulative 
Percentage 
Drug Release 
Cumulative 
Percent Drug 
Remaining 
Log 
cumulative 
Percent Drug 
Remaining 
1 0.5 0.707 -0.301 33.25 1.522 66.75 1.824 
2 1 1.000 0.000 45.59 1.659 54.41 1.736 
3 2 1.414 0.301 65.56 1.817 34.44 1.537 
4 4 2.000 0.602 72.25 1.859 27.75 1.443 
5 6 2.449 0.778 85.65 1.933 14.35 1.157 
6 8 2.828 0.903 93.36 1.970 6.64 0.822 
7 10 3.162 1.000 99.15 1.996 0.85 -0.071 
* Average of three determinations 
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Figure 2: Cumulative Percent Drug Released Vs Time (Zero Order Plots) 
 
Figure 3: Log Cumulative Percent Drug Remaining Vs Time (First Order Plots) 
 
Figure 4: Log Cumulative Percent Drug Released Vs Log Time (Peppas Plots) 
 
CONCLUSION 
In this paper, ethosome formulations containing tretinoin 
as a lipophilic drug have been prepared successfully and 
characterized. It was observed that the presence of 
ethanol in the aqueous compartment of the vesicles 
favoured tretinoin encapsulation. Therefore, the 
inclusion of ethanol in ethosome might play a vital role 
in the enhancement of tretinoin 
permeation. The efficient drug delivery shown here 
together with the long-term stability of ethosomes made 
this system a promising candidate for topical delivery of 
tretinoin. Currently, further studies involving safety on 
skins, pharmacological effect on AD, and mechanism of 
inhibition action for the ethosomal delivery systems 
were being performed. 
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